Display options
Cite
Rose T, Verbeken G, Vos DD, et al. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma. 2014;4(2):66-73
Rose, T., Verbeken, G., Vos, D. D., Merabishvili, M., Vaneechoutte, M., Lavigne, R., Jennes, S., Zizi, M., & Pirnay, J. P. (2014). Experimental phage therapy of burn wound infection: difficult first steps. International journal of burns and trauma, 4(2), 66-73.
Rose, Thomas, et al. "Experimental phage therapy of burn wound infection: difficult first steps." International journal of burns and trauma vol. 4,2 (2014): 66-73.
Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay JP. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma. 2014 Oct 26;4(2):66-73. eCollection 2014. PMID: 25356373; PMCID: PMC4212884.
Copy Download .nbib Format: NLM
Share it on

Int J Burns Trauma. 2014 Oct 26;4(2):66-73. eCollection 2014.

Experimental phage therapy of burn wound infection: difficult first steps.

International journal of burns and trauma

Thomas Rose, Gilbert Verbeken, Daniel De Vos, Maya Merabishvili, Mario Vaneechoutte, Rob Lavigne, Serge Jennes, Martin Zizi, Jean-Paul Pirnay

Affiliations

  1. Burn Wound Center, Queen Astrid Military Hospital Bruynstraat 1, B-1120 Brussel, Belgium.
  2. Laboratory for Molecular and Cellular Technology, Burn Wound Center, Queen Astrid Military Hospital Bruynstraat 1, B-1120 Brussel, Belgium.
  3. Laboratory for Molecular and Cellular Technology, Burn Wound Center, Queen Astrid Military Hospital Bruynstraat 1, B-1120 Brussel, Belgium ; Eliava Institute of Bacteriophage, Microbiology and Virology 3, Gotua street, Tbilisi 0160, Georgia ; Laboratory of Bacteriology Research, University of Ghent De Pintelaan 185, B-9000 Gent, Belgium.
  4. Laboratory of Bacteriology Research, University of Ghent De Pintelaan 185, B-9000 Gent, Belgium.
  5. Laboratory of Gene Technology, Katholieke Universiteit Leuven Kasteelpark Arenberg 21, B-3001 Leuven, Belgium.
  6. Department of Physiology, Vrije Universiteit Brussel Laerbeeklaan 101, B-1090 Brussel, Belgium.

PMID: 25356373 PMCID: PMC4212884

Abstract

Antibiotic resistance has become a major public health problem and the antibiotics pipeline is running dry. Bacteriophages (phages) may offer an 'innovative' means of infection treatment, which can be combined or alternated with antibiotic therapy and may enhance our abilities to treat bacterial infections successfully. Today, in the Queen Astrid Military Hospital, phage therapy is increasingly considered as part of a salvage therapy for patients in therapeutic dead end, particularly those with multidrug resistant infections. We describe the application of a well-defined and quality controlled phage cocktail, active against Pseudomonas aeruginosa and Staphylococcus aureus, on colonized burn wounds within a modest clinical trial (nine patients, 10 applications), which was approved by a leading Belgian Medical Ethical Committee. No adverse events, clinical abnormalities or changes in laboratory test results that could be related to the application of phages were observed. Unfortunately, this very prudent 'clinical trial' did not allow for an adequate evaluation of the efficacy of the phage cocktail. Nevertheless, this first 'baby step' revealed several pitfalls and lessons for future experimental phage therapy and helped overcome the psychological hurdles that existed to the use of viruses in the treatment of patients in our burn unit.

Keywords: Phage therapy; Pseudomonas aeruginosa; Staphylococcus aureus; antibiotic resistance; burn wound; infection

References

  1. Clin Microbiol Rev. 2006 Apr;19(2):403-34 - PubMed
  2. Pharm Res. 2011 Apr;28(4):934-7 - PubMed
  3. Nat Biotechnol. 2004 Jan;22(1):31-6 - PubMed
  4. Burns. 2004 Nov;30(7):660-4 - PubMed
  5. Arch Immunol Ther Exp (Warsz). 2000;48(6):547-51 - PubMed
  6. Nouv Presse Med. 1976 Sep 11;5(29):1831-2 - PubMed
  7. Curr Pharm Biotechnol. 2010 Jan;11(1):69-86 - PubMed
  8. Int J Dermatol. 2002 Jul;41(7):453-8 - PubMed
  9. Wound Repair Regen. 2006 Sep-Oct;14(5):581-5 - PubMed
  10. PLoS One. 2009;4(3):e4944 - PubMed
  11. Burns. 2006 Aug;32(5):644-6 - PubMed
  12. Clin Exp Dermatol. 2005 Jan;30(1):23-6 - PubMed
  13. Antimicrob Agents Chemother. 2007 Jun;51(6):1934-8 - PubMed
  14. J Clin Microbiol. 2003 Mar;41(3):1192-202 - PubMed
  15. Burns Incl Therm Inj. 1988 Jun;14(3):180-4 - PubMed
  16. Annu Rev Food Sci Technol. 2014;5:327-49 - PubMed
  17. J Med Microbiol. 2011 Feb;60(Pt 2):205-10 - PubMed
  18. Antimicrob Agents Chemother. 2001 Mar;45(3):649-59 - PubMed
  19. Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):117-29 - PubMed
  20. J Clin Microbiol. 1998 May;36(5):1347-51 - PubMed
  21. Future Microbiol. 2007 Oct;2(5):485-91 - PubMed
  22. EMBO Rep. 2013 Nov;14(11):951-4 - PubMed
  23. Burns. 1994 Jun;20(3):209-11 - PubMed
  24. Expert Rev Anti Infect Ther. 2013 Sep;11(9):909-15 - PubMed

Publication Types